Biochemical Engineering

Wockhardt joins UK's coronavirus vaccine manufacturing push

Wockhardt joins UK's coronavirus vaccine manufacturing push

4th August 2020

India-based Wockhardt has signed up to complete fill and finish work on millions of COVID-19 vaccine doses for exclusive use in the UK, including AstraZeneca and the University of Oxford's frontrunner candidate. Under a deal with the British government announced Monday, Wockhardt will help supply the country with COVID-19 vaccine doses, using its CP Pharmaceuticals label in Wrexham, North Wales. Source: Fierce Pharma 4/8/2020


Back to group news